维普中文期刊产品整合服务
25篇 您的检索式:作者名="van Gool SW"
    题名 作者 年代 出处 被引量
1Vaccine thera- py in patients with renal cell carcinoma显示文摘VANPOPPEL H JONIAU S VAN GOOL SW 2009Eur Urol2009,55,6:1
2CD80,CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model显示文摘Van Gool SW Vandenberghe P de Boer M 1996Immunol Rev1996,153,10:1
3CD80,CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model显示文摘Van Gool SW Vandenberghe P De Boer M 1996Immunol Rev1996,153,:1
4Phenotype, cytokine production and cytolytic capacity of fresh ( uncultured ) tumourinfiltrating T lymphocytes in human renal cell carcinoma 显示文摘Van den Hove LE Van Gool SW Van Poppel H 1997Clin Exp Immunol1997,109,:1
5Blocking CD40-CD154 and CD80/CD86-CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production显示文摘 Vermeiren J Rafiq K 1999Eur J Immunol1999,29,8:1
6Interaction of CTLA-4(CD152)with CD80 or CD86 inhibits human T-cell activation显示文摘 Van Gool SW Kasran A 1999Immunology1999,98,3:1
7Vaccine therapy in pa-tients with renal cell carcinoma 显示文摘Van Poppel H Joniau S Van Gool SW 2009Eur Urol2009,55,6:1
8The combination of anti-B7 monoclonal antibody and cyclosporin a induces alloantigen-specific anergy during a primary mix lymphocytes reaction 显示文摘 de Boer M Ceuppens JL 1994J Exp Med1994,179,2:1
9Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma显示文摘Van den Hove LE Van Gool SW Van Poppel H 1997Clin Exp Immunol1997,109,3:1
10Blocking CD40-CD154 and CD80/86-CD28 interactions during primary allogenic costimulation results in T cell anergy and high IL-10 production 显示文摘van Gool SW Vermeiren J Rafiq K 1999Eur J Immunol1999,29,8:1
11Disease-and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies 显示文摘Van Gool SW Van Kerschaver E Brock P 2000Leukemia2000,14,12:1
12Peripheral blood lymphocyte subset shifts in patients with untreated hematological tumors: Evidence for systemic activation of the T cell compartment显示文摘Van den Hove LE Vandenberghe P Van Gool SW 1998Leuk Res1998,22,2:1
13Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model显示文摘Maes W van Gool SW 2011Cancer Immunol Immunother2011,60,2:1
14Vaccine therapy in patients with renal cell carcinoma显示文摘Van Poppe! H Joniau S Van Gool SW 2009Eur Urol2009,55,6:1
15CD80, CD86 and CD40 provide accessory signals in a multiple step T-cell activation models显示文摘VAN GOOL SW VANENBERGHE P DE BORE M 1996Immunol Rev1996,153,:1
16Vaccine therapy in patients with renal cell carcinoma 显示文摘Van Poppel H Joniau S Van Gool SW 2009Eur Urol2009,55,6:1
17CD80,CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model显示文摘Van Gool SW Vandenberghe P de Boer M 1996Immunol Rev1996,153,:1
18Interaction of CTLA-4(CD152)with CD80 or CD86 inhibits human T-cell activation显示文摘Vandenborre K Van Gool SW Kasran A 0,,:1
19Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model 显示文摘Maes W Van Gool SW 2013Cancer Immunal Immunother2013,60,2:1
20Blocking CD40-CD154 and CD80/CD86-CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production显示文摘Van Gool SW Vermeiren J Rafiq K Lorr K de Boer M Ceuppens JL 1999Eur J Immunol1999,29,8:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费